Tower Research Capital (TRC)’s Nexalin Technology NXL Stock Holding History

Tower Research Capital (TRC)’s Portfolio NXL Stock Details NXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$736	Sell	2,112 -226	-10%	-$118	﹤0.01%	4793
2025 Q4	$1.3K	Buy	2,338 +907	+63%	+$1.02K	﹤0.01%	4719
2025 Q3	$1.31K	Sell	1,431 -6,091	-81%	-$5.75K	﹤0.01%	4824
2025 Q2	$7.43K	Buy	7,522 +5,891	+361%	+$8.28K	﹤0.01%	4056
2025 Q1	$3.18K	Buy	+1,631	New	+$4.46K	﹤0.01%	4455
2024 Q4	–	Sell	-6,573	Closed	-$4.4K	–	5908
2024 Q3	$4.4K	Sell	6,573 -3,297	-33%	-$3.4K	﹤0.01%	4559
2024 Q2	$16.7K	Buy	9,870 +791	+9%	+$1.16K	﹤0.01%	3858
2024 Q1	$12.7K	Buy	9,079 +8	+0.1%	+$3	﹤0.01%	3456
2023 Q4	$3.67K	Buy	9,071 +5	+0.1%	+$2	﹤0.01%	5052
2023 Q3	$3.99K	Buy	9,066 +4	+0%	+$3	﹤0.01%	4934
2023 Q2	$8.1K	Sell	9,062 -6	-0.1%	-$5	﹤0.01%	4474
2023 Q1	$7K	Buy	9,068 +814	+10%	+$807	﹤0.01%	4759
2022 Q4	$6K	Buy	+8,254	New	+$12.6K	﹤0.01%	4743

Other funds holding NXL

PEAK6 Chicago, Illinois $42.6B AUM 66.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kovack Advisors Ft. Lauderdale, Florida $1.87B AUM 29.51% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s NXL Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Nexalin Technology (NXL) stake by 9.7% in Q1 2026, selling an estimated $118 and leaving 2,112 shares worth $736. The position accounts for ﹤0.01% of the portfolio, ranked #4793.

Tower Research Capital (TRC) first reported a position in NXL in Q4 2022 and has held it in 13 quarters since. The position peaked at $16.7K in Q2 2024. 23 funds tracked by Wall St. Rank hold NXL as of Q1 2026.

Tower Research Capital (TRC) held 2,112 shares of Nexalin Technology worth $736 as of Q1 2026.
Tower Research Capital (TRC) sold 226 Nexalin Technology shares in Q1 2026, an estimated $118.
Nexalin Technology made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4793 holding.
Tower Research Capital (TRC) first reported a position in Nexalin Technology in Q4 2022 and has held it in 13 quarters since.
Tower Research Capital (TRC)'s Nexalin Technology position peaked at $16.7K in Q2 2024.
23 funds tracked by Wall St. Rank held Nexalin Technology as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.